139 related articles for article (PubMed ID: 7929177)
1. Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate.
Shworak NW; Shirakawa M; Colliec-Jouault S; Liu J; Mulligan RC; Birinyi LK; Rosenberg RD
J Biol Chem; 1994 Oct; 269(40):24941-52. PubMed ID: 7929177
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line.
Shworak NW; Kojima T; Rosenberg RD
Haemostasis; 1993 Mar; 23 Suppl 1():161-76. PubMed ID: 8495865
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a cell mutant specifically defective in the synthesis of anticoagulantly active heparan sulfate.
Colliec-Jouault S; Shworak NW; Liu J; de Agostini AI; Rosenberg RD
J Biol Chem; 1994 Oct; 269(40):24953-8. PubMed ID: 7929178
[TBL] [Abstract][Full Text] [Related]
4. Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool.
Shworak NW; Fritze LM; Liu J; Butler LD; Rosenberg RD
J Biol Chem; 1996 Oct; 271(43):27063-71. PubMed ID: 8900197
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.
Kojima T; Leone CW; Marchildon GA; Marcum JA; Rosenberg RD
J Biol Chem; 1992 Mar; 267(7):4859-69. PubMed ID: 1537864
[TBL] [Abstract][Full Text] [Related]
6. The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate biosynthesis in F9 embryonal carcinoma cells.
Zhang L; Schwartz JJ; Miller J; Liu J; Fritze LM; Shworak NW; Rosenberg RD
J Biol Chem; 1998 Oct; 273(43):27998-8003. PubMed ID: 9774414
[TBL] [Abstract][Full Text] [Related]
7. Characterization of ryudocan glycosaminoglycan acceptor sites.
Shworak NW; Shirakawa M; Mulligan RC; Rosenberg RD
J Biol Chem; 1994 Aug; 269(33):21204-14. PubMed ID: 7520439
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells.
Zhang L; Yoshida K; Liu J; Rosenberg RD
J Biol Chem; 1999 Feb; 274(9):5681-91. PubMed ID: 10026187
[TBL] [Abstract][Full Text] [Related]
9. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase.
Liu J; Shworak NW; Fritze LM; Edelberg JM; Rosenberg RD
J Biol Chem; 1996 Oct; 271(43):27072-82. PubMed ID: 8900198
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.
Kojima T; Shworak NW; Rosenberg RD
J Biol Chem; 1992 Mar; 267(7):4870-7. PubMed ID: 1537865
[TBL] [Abstract][Full Text] [Related]
11. New approaches for defining the molecular basis of anticoagulantly active heparan sulfate production.
De Agostini AI; Rosenberg RD
Ann N Y Acad Sci; 1991; 614():279-88. PubMed ID: 2024889
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of ryudocan, an endothelial heparan sulfate proteoglycan.
Kojima T
Semin Thromb Hemost; 2000; 26(1):67-73. PubMed ID: 10805285
[TBL] [Abstract][Full Text] [Related]
13. Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1.
Kokenyesi R; Bernfield M
J Biol Chem; 1994 Apr; 269(16):12304-9. PubMed ID: 8163535
[TBL] [Abstract][Full Text] [Related]
14. Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor.
Kojima T; Katsumi A; Yamazaki T; Muramatsu T; Nagasaka T; Ohsumi K; Saito H
J Biol Chem; 1996 Mar; 271(10):5914-20. PubMed ID: 8621465
[TBL] [Abstract][Full Text] [Related]
15. New approaches for defining sequence specific synthesis of heparan sulfate chains.
Rosenberg RD; de Agostini AI
Adv Exp Med Biol; 1992; 313():307-16. PubMed ID: 1442267
[TBL] [Abstract][Full Text] [Related]
16. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.
Marcum JA; Atha DH; Fritze LM; Nawroth P; Stern D; Rosenberg RD
J Biol Chem; 1986 Jun; 261(16):7507-17. PubMed ID: 2940242
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts.
Lories V; Cassiman JJ; Van den Berghe H; David G
J Biol Chem; 1992 Jan; 267(2):1116-22. PubMed ID: 1339431
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning, genomic organization, promoter activity, and tissue-specific expression of the mouse ryudocan gene.
Tsuzuki S; Kojima T; Katsumi A; Yamazaki T; Sugiura I; Saito H
J Biochem; 1997 Jul; 122(1):17-24. PubMed ID: 9276666
[TBL] [Abstract][Full Text] [Related]
19. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway.
Zhang L; Beeler DL; Lawrence R; Lech M; Liu J; Davis JC; Shriver Z; Sasisekharan R; Rosenberg RD
J Biol Chem; 2001 Nov; 276(45):42311-21. PubMed ID: 11551899
[TBL] [Abstract][Full Text] [Related]
20. [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells].
Nishinaga M; Shimada K
Rinsho Byori; 1994 Apr; 42(4):340-5. PubMed ID: 8176841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
